d88×ðÁúz6(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹Ù·½ÍøÕ¾-×·Çó¿µ½¡ÄãÎÒÒ»Æð³É

¡¾Ë«Óï¾ý¡¿Öذõ£¡Öйúйڲ¡¶¾ÒßÃç»ñÅúÉÏÊÐ
Ðû²¼Ê±¼ä£º2020-12-31

ת×ÔË«Óï¾ý

       12ÔÂ31ÈÕ£¬£¬£¬£¬£¬¹úÎñÔºÁª·ÀÁª¿Ø»úÖÆÐû²¼£¬£¬£¬£¬£¬d88×ðÁúz6(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹Ù·½ÍøÕ¾-×·Ç󽡿µÄãÎÒÒ»Æð³ÉÖйúÉúÎïйÚÃð»îÒßÃçÒÑ»ñµÃ¹ú¼ÒÒ©¼à¾ÖÅú×¼¸½Ìõ¼þÉÏÊС£ ¡£¡£¡£¡£¡£¡£¡£

       China announced it has granted conditional market approval for its first COVID-19 vaccine during a Thursday news conference.

       The vaccine, developed by State-owned Sinopharm, was approved by China's top drug regulator on Wednesday night, said Chen Shifei, deputy head of the National Medical Products Administration.

       ¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾Ö¸±¾Ö³¤³Âʱ·É³Æ£¬£¬£¬£¬£¬¹ú¼ÒÒ©¼à¾ÖÒÑÓÚ30ÈÕ¸½Ìõ¼þÅú×¼ÁËd88×ðÁúz6(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹Ù·½ÍøÕ¾-×·Ç󽡿µÄãÎÒÒ»Æð³ÉÖйúÉúÎï±±¾©¹«Ë¾Ð¹ڲ¡¶¾Ãð»îÒßÃç×¢²áÉêÇë¡£ ¡£¡£¡£¡£¡£¡£¡£

       ÒÑÓÐÊý¾ÝÏÔʾ£¬£¬£¬£¬£¬ÒßÃç±£»£»£»£»£» £»£»¤ÂÊΪ79.34%£¬£¬£¬£¬£¬ÊµÏÖÇå¾²ÐÔ¡¢ÓÐÓÃÐÔ¡¢¿É¼°ÐÔ¡¢¿É¼ç¸ºÐÔµÄͳһ£¬£¬£¬£¬£¬µÖ´ïÌìÏÂÎÀÉú×éÖ¯¼°¹ú¼ÒÒ©¼à¾ÖÏà¹Ø±ê×¼ÒªÇó¡£ ¡£¡£¡£¡£¡£¡£¡£ºóÐø£¬£¬£¬£¬£¬ÒßÃçÃâÒߵij¤ÆÚÐԺͱ£»£»£»£»£» £»£»¤Ð§¹û»¹ÐèÒ»Á¬ÊӲ졣 ¡£¡£¡£¡£¡£¡£¡£

       The vaccine is generally safe and has a 79.34 percent efficacy rate according to clinical results released by the company on Wednesday. Strict supervision will continue to be carried out over the vaccine after its approval to ensure its safety and quality, Chen said.

       ÕâһЧ¹ûÀ´Ö®²»Ò×£¬£¬£¬£¬£¬ÖйúÒßÃçÉÏÊÐΪȫÇòսʤÒßÇé×¢ÈëÐÅÐÄ£¬£¬£¬£¬£¬Ò²ÎªÒßÃç³ÉΪȫÇò¹«¹²²úÆ·ÌṩÓÐÁ¦Ö§³Ö¡£ ¡£¡£¡£¡£¡£¡£¡£

µØµã£º±±¾©Êк£µíÇøÖª´ºÂ·20ºÅ ÖйúÒ½Ò©´óÏÃ

Óʱࣺ100191

µç»°£º86-10-82287727

´«Õ棺86-10-62033332

°æÈ¨ËùÓУºd88×ðÁúz6(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹Ù·½ÍøÕ¾-×·Ç󽡿µÄãÎÒÒ»Æð³É

¾©¹«Íø°²±¸ 11040102700104ºÅ

¾©ICP±¸£º14023670ºÅ-1
¡¾Ë«Óï¾ý¡¿Öذõ£¡Öйúйڲ¡¶¾ÒßÃç»ñÅúÉÏÊÐ
Ðû²¼Ê±¼ä£º2020-12-31

ת×ÔË«Óï¾ý

       12ÔÂ31ÈÕ£¬£¬£¬£¬£¬¹úÎñÔºÁª·ÀÁª¿Ø»úÖÆÐû²¼£¬£¬£¬£¬£¬d88×ðÁúz6(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹Ù·½ÍøÕ¾-×·Ç󽡿µÄãÎÒÒ»Æð³ÉÖйúÉúÎïйÚÃð»îÒßÃçÒÑ»ñµÃ¹ú¼ÒÒ©¼à¾ÖÅú×¼¸½Ìõ¼þÉÏÊС£ ¡£¡£¡£¡£¡£¡£¡£

       China announced it has granted conditional market approval for its first COVID-19 vaccine during a Thursday news conference.

       The vaccine, developed by State-owned Sinopharm, was approved by China's top drug regulator on Wednesday night, said Chen Shifei, deputy head of the National Medical Products Administration.

       ¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾Ö¸±¾Ö³¤³Âʱ·É³Æ£¬£¬£¬£¬£¬¹ú¼ÒÒ©¼à¾ÖÒÑÓÚ30ÈÕ¸½Ìõ¼þÅú×¼ÁËd88×ðÁúz6(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹Ù·½ÍøÕ¾-×·Ç󽡿µÄãÎÒÒ»Æð³ÉÖйúÉúÎï±±¾©¹«Ë¾Ð¹ڲ¡¶¾Ãð»îÒßÃç×¢²áÉêÇë¡£ ¡£¡£¡£¡£¡£¡£¡£

       ÒÑÓÐÊý¾ÝÏÔʾ£¬£¬£¬£¬£¬ÒßÃç±£»£»£»£»£» £»£»¤ÂÊΪ79.34%£¬£¬£¬£¬£¬ÊµÏÖÇå¾²ÐÔ¡¢ÓÐÓÃÐÔ¡¢¿É¼°ÐÔ¡¢¿É¼ç¸ºÐÔµÄͳһ£¬£¬£¬£¬£¬µÖ´ïÌìÏÂÎÀÉú×éÖ¯¼°¹ú¼ÒÒ©¼à¾ÖÏà¹Ø±ê×¼ÒªÇó¡£ ¡£¡£¡£¡£¡£¡£¡£ºóÐø£¬£¬£¬£¬£¬ÒßÃçÃâÒߵij¤ÆÚÐԺͱ£»£»£»£»£» £»£»¤Ð§¹û»¹ÐèÒ»Á¬ÊӲ졣 ¡£¡£¡£¡£¡£¡£¡£

       The vaccine is generally safe and has a 79.34 percent efficacy rate according to clinical results released by the company on Wednesday. Strict supervision will continue to be carried out over the vaccine after its approval to ensure its safety and quality, Chen said.

       ÕâһЧ¹ûÀ´Ö®²»Ò×£¬£¬£¬£¬£¬ÖйúÒßÃçÉÏÊÐΪȫÇòսʤÒßÇé×¢ÈëÐÅÐÄ£¬£¬£¬£¬£¬Ò²ÎªÒßÃç³ÉΪȫÇò¹«¹²²úÆ·ÌṩÓÐÁ¦Ö§³Ö¡£ ¡£¡£¡£¡£¡£¡£¡£

µØµã£º±±¾©Êк£µíÇøÖª´ºÂ·20ºÅ ÖйúÒ½Ò©´óÏÃ

Óʱࣺ100191 µç»°£º86-10-82287727

´«Õ棺86-10-62033332

°æÈ¨ËùÓУºd88×ðÁúz6(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹Ù·½ÍøÕ¾-×·Ç󽡿µÄãÎÒÒ»Æð³É

¹«°²±¸°¸ºÅ£º11040102700104ºÅ


¾©ICP±¸£º14023670ºÅ-1
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿